Nagoya University in Japan collaborated with Fujifilm to develop a novel lipid nanoparticle. For the first time, capped circular RNA was efficiently delivered to animals. The activity was increased tenfold and inflammation was extremely low, opening a new door for the next generation of long-lasting mRNA therapy. The relevant paper was published in the new issue of “Cells and Biomaterials”.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.